Micro Labs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is BESIFLOXACIN HYDROCHLORIDE, with a corresponding US DMF Number 31989.
Remarkably, this DMF maintains an Active status since its submission on November 30, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 22, 2017, and payment made on December 02, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II